申请人:GREGOR Vlad Edward
公开号:US20120065233A1
公开(公告)日:2012-03-15
The present disclosure relates to the field of tyrosine kinase enzyme inhibition, in particular anaplastic lymphoma kinase (ALK) inhibition using novel small molecules. Provided are compounds capable to modulate ALK activity, compositions that comprise the compounds, and methods of using the compounds for the treatment or prevention of diseases or conditions that are characterized by ALK activity or expression.
本公开涉及酪氨酸激酶酶抑制领域,特别是使用新型小分子抑制间变性淋巴瘤激酶(ALK)的抑制。提供了能够调节ALK活性的化合物、包含这些化合物的组合物以及使用这些化合物治疗或预防由ALK活性或表达特征的疾病或病症的方法。